ClinVar Miner

Submissions for variant NM_205768.3(ZBTB18):c.1391G>T (p.Arg464Leu)

dbSNP: rs1558149913
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
3billion, Medical Genetics RCV002251239 SCV002521795 likely pathogenic Intellectual disability, autosomal dominant 22 2022-05-22 criteria provided, single submitter clinical testing Different pathogenic amino acid change has been reported with sufficient evidence at the same codon (ClinVar ID: VCV000440857,VCV000617452, PMID:27598823, 28283832). The variant is located in a well-established functional domain or exonic hotspot, where pathogenic variants have frequently reported. In silico prediction tools and conservation analysis predicted that this variant was probably damaging to the protein structure/function (3CNET: 0.973>=0.75). It is absent from the gnomAD v2.1.1 dataset. Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV004556095 SCV005045234 likely pathogenic Intellectual disability 2024-05-17 criteria provided, single submitter curation The heterozygous p.Arg464Leu variant in ZBTB18 was identified by our study in one individual with intellectual developmental disorder. Trio exome analysis showed this variant to be de novo. The variant is absent from large population studies. This variant has been reported in ClinVar (Variation ID: 1687557) and has been interpreted as likely pathogenic by 3billion. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The number of missense variants reported in ZBTB18 in the general population is lower than expected, suggesting there is little benign variation in this gene and slightly increasing the possibility that a missense variant in this gene may not be tolerated. Two additional pathogenic variants, resulting in a different amino acid change at the same position, (p.Arg464Cys and Arg464His), have been reported in association with disease in the literature, supporting that a change at this position may not be tolerated (Variation IDs: 440857, 617452). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal dominant intellectual developmental disorder 22. ACMG/AMP Criteria applied: PS2_Supporting, PM2_Supporting, PP2, PM5_Strong (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.